During the past decade, Covance conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance" #1 collaborator was "Akcea Therapeutics" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Covance" are "Healthy" (17 trials), "Healthy Subjects" (2 trials), "Abnormalities, Cardiovascular" (1 trials), "Bioavailability of ASP015K" (1 trials) and "Celiac Disease" (1 trials). Many other conditions were trialed in "Covance" in a lesser frequency.

Most popular intervention types in "Covance" are "Drug" (19 trials), "Biological" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Galcanezumab" (2 trials), "Ixekizumab" (2 trials), "LY3074828" (2 trials) and "LY3372689" (2 trials). Other intervention names were less common.

The vast majority of trials in "Covance" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Covance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Covance, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Covance, 22 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".